LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Nintedanib | 0.04 | uM | LJP6 | 2 | H06 | 72 | hr | 1209 | 4293 | 4093 | 1.0486 | 1.0547 |
MCF7 | Nintedanib | 0.04 | uM | LJP6 | 3 | H06 | 72 | hr | 1209 | 4061 | 4121 | 0.9854 | 0.9834 |
MCF7 | Nintedanib | 0.12 | uM | LJP6 | 1 | H05 | 72 | hr | 1209 | 3696 | 3823 | 0.9668 | 0.9597 |
MCF7 | Nintedanib | 0.12 | uM | LJP6 | 2 | H05 | 72 | hr | 1209 | 4051 | 4093 | 0.9895 | 0.9881 |
MCF7 | Nintedanib | 0.12 | uM | LJP6 | 3 | H05 | 72 | hr | 1209 | 4036 | 4121 | 0.9793 | 0.9765 |
MCF7 | Nintedanib | 0.37 | uM | LJP6 | 1 | H04 | 72 | hr | 1209 | 3441 | 3823 | 0.9001 | 0.8771 |
MCF7 | Nintedanib | 0.37 | uM | LJP6 | 2 | H04 | 72 | hr | 1209 | 3525 | 4093 | 0.8611 | 0.8369 |
MCF7 | Nintedanib | 0.37 | uM | LJP6 | 3 | H04 | 72 | hr | 1209 | 3518 | 4121 | 0.8536 | 0.8288 |
MCF7 | Nintedanib | 1.11 | uM | LJP6 | 1 | H03 | 72 | hr | 1209 | 2561 | 3823 | 0.6699 | 0.5712 |
MCF7 | Nintedanib | 1.11 | uM | LJP6 | 2 | H03 | 72 | hr | 1209 | 3020 | 4093 | 0.7377 | 0.6824 |
MCF7 | Nintedanib | 1.11 | uM | LJP6 | 3 | H03 | 72 | hr | 1209 | 2873 | 4121 | 0.6971 | 0.6309 |
MCF7 | Nintedanib | 3.33 | uM | LJP6 | 1 | H02 | 72 | hr | 1209 | 2332 | 3823 | 0.6100 | 0.4850 |
MCF7 | Nintedanib | 3.33 | uM | LJP6 | 2 | H02 | 72 | hr | 1209 | 2366 | 4093 | 0.5779 | 0.4644 |
MCF7 | Nintedanib | 3.33 | uM | LJP6 | 3 | H02 | 72 | hr | 1209 | 2536 | 4121 | 0.6154 | 0.5198 |
MCF7 | Nintedanib | 10 | uM | LJP6 | 1 | H01 | 72 | hr | 1209 | 1300 | 3823 | 0.3401 | 0.0444 |
MCF7 | Nintedanib | 10 | uM | LJP6 | 2 | H01 | 72 | hr | 1209 | 1361 | 4093 | 0.3325 | 0.0694 |
MCF7 | Nintedanib | 10 | uM | LJP6 | 3 | H01 | 72 | hr | 1209 | 1498 | 4121 | 0.3635 | 0.1286 |
MCF7 | Foretinib | 0.04 | uM | LJP5 | 1 | H12 | 72 | hr | 1209 | 4436 | 3980 | 1.1146 | 1.1303 |
MCF7 | Foretinib | 0.04 | uM | LJP5 | 2 | H12 | 72 | hr | 1209 | 3976 | 4252 | 0.9349 | 0.9272 |
MCF7 | Foretinib | 0.04 | uM | LJP5 | 3 | H12 | 72 | hr | 1209 | 4559 | 4376 | 1.0418 | 1.0446 |
MCF7 | Foretinib | 0.12 | uM | LJP5 | 1 | H11 | 72 | hr | 1209 | 2644 | 3980 | 0.6643 | 0.5764 |
MCF7 | Foretinib | 0.12 | uM | LJP5 | 2 | H11 | 72 | hr | 1209 | 2987 | 4252 | 0.7024 | 0.6460 |
MCF7 | Foretinib | 0.12 | uM | LJP5 | 3 | H11 | 72 | hr | 1209 | 2938 | 4376 | 0.6714 | 0.6135 |
MCF7 | Foretinib | 0.37 | uM | LJP5 | 1 | H10 | 72 | hr | 1209 | 1416 | 3980 | 0.3558 | 0.0960 |
MCF7 | Foretinib | 0.37 | uM | LJP5 | 2 | H10 | 72 | hr | 1209 | 1582 | 4252 | 0.3720 | 0.1595 |